Immunology Research
Click the below button to learn more about our autoimmune disease research and clinical trials.
Learn MoreThe purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes one required visit to the study site, with the remainder of assessments performed in the home or by phone.
Participants must test positive for COVID-19 within three days before starting the study
Participants must have mild to moderate COVID-19 illness
Participants may have at least one of the following: Fever, cough, sore throat, not feeling well, headache, muscle pain, digestive symptoms, or shortness of breath when active
Participants must not need a machine to help them breathe (ventilator)
Mothers must not be breastfeeding
Click the below button to learn more about our autoimmune disease research and clinical trials.
Learn MoreWith the help of research study participants, we are learning about pediatric conditions and potential new approaches to treating disease.
Learn MoreA clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.